 prevalence tardive dyskinesia neuroleptic-treated diabetics controlled study controlled study prevalence tardive dyskinesia neuroleptic-treated diabetics prevalence tardive dyskinesia group nondiabetic neuroleptic-treated controls age sex psychiatric diagnosis dose duration neuroleptic treatment Members group movement disorders rater standard rating scales blind diagnoses treatments Neuroleptic-treated diabetics prevalence severity tardive dyskinesia differences groups possible risk factors tardive dyskinesia parkinsonism anticholinergic drug treatment cognitive function data mellitus risk factor tardive dyskinesia